Adaptive Platform Trial (ATP) Accelerates Dementia Research
Summary: The Alzheimer’s Tau Platform (ATP) trial is the first large-scale study specifically designed to evaluate combination therapies that target both amyloid plaques and tau tangles at once. Uniquely, ATP screens and treats people who are asymptomatic but show early biological indicators of Alzheimer’s on advanced imaging, with the aim of interrupting the disease process … Read more